BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20428826)

  • 41. Expression of the Shwachman-Bodian-Diamond syndrome (SBDS) protein in human pancreatic cancer and chronic pancreatitis.
    Kayed H; Bekasi S; Keleg S; Welsch T; Esposito I; Shimamura A; Michalski CW; Friess H; Kleeff J
    Histol Histopathol; 2008 Jul; 23(7):819-26. PubMed ID: 18437680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expression and clinical significance of AHSG and complement C3 in pancreatic ductal adenocarcinoma].
    Chen J; Wu W; Chen L; Ma X; Zhao Y; Zhou H; Yang R; Hu L
    Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(28):2175-9. PubMed ID: 25331466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
    Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z
    World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Snail transcript levels in diagnosis of pancreatic carcinoma with fine-needle aspirate.
    Wang Z; Zhao L; Xiao Y; Gao Y; Zhao C
    Br J Biomed Sci; 2015; 72(3):107-10. PubMed ID: 26510265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.
    Makawita S; Smith C; Batruch I; Zheng Y; Rückert F; Grützmann R; Pilarsky C; Gallinger S; Diamandis EP
    Mol Cell Proteomics; 2011 Oct; 10(10):M111.008599. PubMed ID: 21653254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive proteomic analysis of human pancreatic juice.
    Grønborg M; Bunkenborg J; Kristiansen TZ; Jensen ON; Yeo CJ; Hruban RH; Maitra A; Goggins MG; Pandey A
    J Proteome Res; 2004; 3(5):1042-55. PubMed ID: 15473694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of the tissue plasminogen activator as a prognostic and differentiation factor in patients with pancreatic cancer and chronic pancreatitis.
    Baluka D; Urbanek T; Lekstan A; Swietochowska E; Wiaderkiewicz R; Kajor M; Jedrzejewska-Szypulka H; Kusnierz K; Lampe P
    J Physiol Pharmacol; 2016 Feb; 67(1):93-101. PubMed ID: 27010898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of pancreatitis-associated protein (PAP) in human pancreatic ductal adenocarcinoma.
    Xie MJ; Motoo Y; Iovanna JL; Su SB; Ohtsubo K; Matsubara F; Sawabu N
    Dig Dis Sci; 2003 Mar; 48(3):459-64. PubMed ID: 12757156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
    PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients.
    Schubert S; Traub F; Brakensiek K; von Kopylow K; Marohn B; Maelzer M; Gaedcke J; Kreipe H; Stuhrmann M
    Pancreas; 2014 Oct; 43(7):1078-82. PubMed ID: 25003218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
    Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2016; 17(4):437-444. PubMed ID: 27802195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
    Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
    Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Sakai H; Fujita H; Nakata K; Tanaka M
    Ann Surg Oncol; 2010 Dec; 17(12):3120-8. PubMed ID: 20652642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
    Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
    Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis.
    Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Sep; 12(18):5417-22. PubMed ID: 17000675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
    Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
    Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.
    Xue YZ; Sheng YY; Liu ZL; Wei ZQ; Cao HY; Wu YM; Lu YF; Yu LH; Li JP; Li ZS
    Tumour Biol; 2013 Apr; 34(2):895-9. PubMed ID: 23247867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Free proteolytic enzymes in pancreatic juice of patients with acute pancreatitis.
    Geokas MC; Rinderknecht H
    Am J Dig Dis; 1974 Jul; 19(7):591-8. PubMed ID: 4835329
    [No Abstract]   [Full Text] [Related]  

  • 60. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma.
    Shekouh AR; Thompson CC; Prime W; Campbell F; Hamlett J; Herrington CS; Lemoine NR; Crnogorac-Jurcevic T; Buechler MW; Friess H; Neoptolemos JP; Pennington SR; Costello E
    Proteomics; 2003 Oct; 3(10):1988-2001. PubMed ID: 14625861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.